<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Nov. 26, 2019 (HealthDay News) — In an expert panel consensus, published online Nov. 12 in the Journal of the American Academy of Dermatology<\/i>, opioid-prescribing guidelines are presented for common dermatologic procedures.<\/p>\n
Justin M. McLawhorn, M.D., from the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues used a four-step modified Delphi method to conduct a systematic discussion to develop opioid-prescribing guidelines for common dermatologic scenarios. The guidelines were developed for patients who were opioid-naive and undergoing routine procedures.<\/p>\n
The researchers found that after most uncomplicated procedures (76 percent), postoperative pain can be adequately managed with acetaminophen and\/or ibuprofen. No specific dermatologic scenarios were identified that routinely require more than 15 oxycodone 5-mg oral equivalents to manage postoperative pain. Twenty-three percent of procedural scenarios routinely required one to 10 opioid tablets based on group consensus, while one to 15 opioid tablets were routinely required for only one procedural scenario.<\/p>\n
“While not exhaustive, these guidelines provide additional resources to help address many uncertainties involved with the management of postoperative pain, and may be used as a starting point to formulate a pain management plan,” the authors write.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n